Inflammation and intracranial aneurysms

Neurosurgery

Volumn 45, Issue 5, 1999, Pages 1137-1147

  Chyatte, Douglas ^a   Bruno, Gerard ^a   Desai, Shailesh ^a   Todor, D Roxanne ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Complement; Immunoglobulin; Inflammation; Intracranial aneurysm; Macrophage; T lymphocytes; Vascular cell adhesion molecule

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C9; IMMUNOGLOBULIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANEURYSM SURGERY; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN ARTERY ANEURYSM RUPTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; MACROPHAGE; MALE; MICROSURGERY; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANEURYSM, RUPTURED; BASILAR ARTERY; COMPLEMENT C3C; COMPLEMENT C9; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTRACRANIAL ANEURYSM; MACROPHAGES; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PROGNOSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T-LYMPHOCYTES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032744212     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199911000-00024     Document Type: Article

References (79)

1. Babaev VR, Bobryshev YV, Sukhova GK, Kasantseva IA: Monocyte/macrophage accumulation and smooth muscle cell phenotypes in early atherosclerotic lesions of human aorta. Atherosclerosis 100:237-248, 1993.
2. Baker CJ, Fiore A, Connolly ES Jr, Baker KZ, Solomon RA: Serum elastase and α1-antitrypsin levels in patients with ruptured and unruptured cerebral aneurysms. Neurosurgery 37:56-61, 1995.
3. Brott T, Mandybur TI: Case-control study of clinical outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery 19:891-895, 1986.
4. Bruno G, Todor R, Lewis I, Chyatte D: Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg 89:431-440, 1998.
5. Cajander S, Hassler O: Enzymatic destruction of the elastic lamella at the mouth of cerebral berry aneurysm? An ultrastructural study with special regard to the elastic tissue. Acta Neurol Scand 53:171-181, 1976.
6. Capella JF, Paik DC, Yin NX, Gervasoni JE, Tilson MD: Complement activation and subclassification of tissue immunoglobulin G in the abdominal aortic aneurysm. J Surg Res 65:31-33, 1996.
7. Chyatte D: The epidemiology, genetics and clinical behavior of intracranial aneurysms, in Awad IA (ed): Current Management of Cerebral Aneurysms. Park Ridge, AANS, 1995, pp 1-20.
8. Chyatte D, Lewis I: Gelatinase activity and the occurrence of cerebral aneurysms. Stroke 28:799-804, 1997.
9. Chyatte D, Chen TL, Bronstein K, Brass LM: Seasonal fluctuation in the incidence of intracranial aneurysm rupture and its relationship to changing climatic conditions. J Neurosurg 81:525-530, 1994.
10. Couffinhal T, Duplaa C, Moreau C, Lamaziere JM, Bonnet J: Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ Res 74:225-234, 1994.
11. Crompton MR: Mechanism of growth and rupture in cerebral berry aneurysms. Br Med J 1:1138-1142, 1966.
12. Crompton MR: The comparative pathology of cerebral aneurysms. Brain 89:789-796, 1966.
13. Crompton MR: The pathogenesis of cerebral aneurysms. Brain 89:797-814, 1966.
14. De Braekeleer M, Perusse L, Cantin L, Bouchard JM, Mathieu J: A study of inbreeding and kinship in intracranial aneurysms in the Saguenay Lac-Saint-Jean region (Quebec, Canada). Ann Hum Genet 60:99-104, 1996.
15. de la Monte SM, Moore GW, Monk MA, Hutchins GM: Risk factors for the development and rupture of intracranial berry aneurysms. Am J Med 78:957-964, 1985.
16. Endres M, Laufs U, Merz H, Kaps M: Focal expression of intercellular adhesion molecule-1 in the human carotid bifurcation. Stroke 28:77-82, 1997.
17. Forbes G, Fox AJ, Huston J III, Wiebers DO, Torner J: Interobserver variability in angiographic measurement and morphologic characterization of intracranial aneurysms: A report from the International Study of Unruptured Intracranial Aneurysms. AJNR Am J Neuroradiol 17:1407-1415, 1996.
18. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT: Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15:1145-1151, 1995.
19. Gaetani P, Tartara F, Grazioli V, Tancioni F, Infuso L, Rodriguez y Baena R: Collagen cross-linkage, elastolytic and collagenolytic activities in cerebral aneurysms: A preliminary investigation. Life Sci 63:285-292, 1998.
20. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503, 1994.
21. Garraway WM, Whisnant JP: The changing pattern of hypertension and the declining incidence of stroke. JAMA 258:214-217, 1987.
22. Gregory AK, Yin NX, Capella J, Xia S, Newman KM, Tilson MD: Features of autoimmunity in the abdominal aortic aneurysm. Arch Surg 131:85-88, 1996.
23. Handler FP, Blumenthal HT: Inflammatory factors in the pathogenesis of cerebrovascular aneurysms. JAMA 155:1479-1483, 1954.
24. Hansson GK: Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J 69[Suppl 1]:S38-S41, 1993.
25. Hansson GK: Immune and inflammatory mechanisms in the pathogenesis of atherosclerosis. J Atheroscler Thromb 1[Suppl 1]: S6-S9, 1994.
26. Haraoka S, Shimokama T, Watanabe T: Role of T lymphocytes in the pathogenesis of atherosclerosis: Animal studies using athymic nude rats. Ann N Y Acad Sci 811:515-518, 1997.
27. Hashimoto N, Handa H, Nagata I, Hazama F: Animal model of cerebral aneurysms: Pathology and pathogenesis of induced cerebral aneurysms in rats. Neurol Res 6:33-40, 1984.
28. Henry PD, Chen CH: Inflammatory mechanisms of atheroma formation: Influence of fluid mechanics and lipid-derived inflammatory mediators. Am J Hypertens 6:328S-334S, 1993.
29. Hirose H, Ozsvath KJ, Xia S, Tilson MD: Molecular cloning of the complementary DNA for an additional member of the family of aortic aneurysm antigenic proteins. J Vasc Surg 26:313-318, 1997.
30. Ingall TJ, Whisnant JP, Wiebers DO, O'Fallon WM: Has there been a decline in subarachnoid hemorrhage mortality? Stroke 20:718-724, 1989.
31. Jang IK, Lassila R, Fuster V: Atherogenesis and inflammation. Eur Heart J 14[Suppl K]:2-6, 1993.
32. Juvela S, Hillbom M, Numminen H, Koskinen P: Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke 24:639-646, 1993.
33. King JT Jr: Epidemiology of aneurysmal subarachnoid hemorrhage. Neuroimaging Clin N Am 7:659-668, 1997.
34. Koch AE, Haines GK, Rizzo RJ, Radosevich JA, Pope RM, Robinson PG, Pearce WH: Human abdominal aortic aneurysms: Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 137:1199-1213, 1990.
35. Konttinen YT, Ceponis A, Meri S, Vuorikoski A, Kortekangas P, Sorsa, T, Sukura A, Santavirta S: Complement in acute and chronic arthritides: Assessment of C3c, C9, and protectin (CD59) in synovial membrane. Ann Rheum Dis 55:888-894, 1996.
36. Kosierkiewicz TA, Factor SM, Dickson DW: Immunocytochemical studies of atherosclerotic lesions of cerebral berry aneurysms. J Neuropathol Exp Neurol 53:399-406, 1994.
37. Leblanc R: Familial cerebral aneurysms: A bias for women. Stroke 27:1050-1054, 1996.
38. Leblanc R, Melanson D, Tampieri D, Guttmann RD: Familial cerebral aneurysms: A study of 13 families. Neurosurgery 37:633-638, 1995.
39. Li Z, Li L, Zielke HR, Cheng L, Xiao R, Crow MT, Stetler-Stevenson WG, Froehlich J, Lakatta EG: Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 148:121-128, 1996.
40. Ljunggren B, Saveland H, Brandt L, Zygmunt S: Early operation and overall outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 62:547-551, 1985.
41. Longstreth WT Jr, Nelson LM, Koepsell TD, van Belle G: Cigarette smoking, alcohol use, and subarachnoid hemorrhage. Stroke 23: 1242-1249, 1992.
42. Marshman LA: Elastin degradation in the superficial temporal arteries of patients with intracranial aneurysms reflects changes in plasma elastase. Neurosurgery 43:982, 1998 (letter).
43. McAnerney JM, Johnson S, Schoub BD: Surveillance of respiratory viruses: A 10-year laboratory-based study. S Afr Med J 84:473-477, 1994.
44. Nakai K, Itoh C, Kawazoe K, Miura Y, Sotoyanagi H, Hotta K, Itoh T, Kamata J, Hiramori K: Concentration of soluble vascular cell adhesion molecule-1 (VCAM-1) correlated with expression of VCAM-1 mRNA in the human atherosclerotic aorta. Coron Artery Dis 6:497-502, 1995.
45. Newman KM, Jean-Claude J, Li H, Ramey WG, Tilson MD: Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 90:II224-II227, 1994.
46. Norrgard O, Angquist KA, Fodstad H, Forsell A, Lindberg M: Intracranial aneurysms and heredity. Neurosurgery 20:236-239, 1987.
47. Ozsvath KJ, Hirose H, Xia S, Chew D, Knoetgen J III, Tilson MD: Expression of two novel recombinant proteins from aortic adventitia (kappafibs) sharing amino acid sequences with cytomegalo-virus. J Surg Res 69:277-282, 1997.
48. Ozsvath KJ, Hirose H, Xia S, Tilson MD: Molecular mimicry in human aortic aneurysmal diseases. Ann N Y Acad Sci 800:288-293, 1996.
49. Ozsvath KJ, Xia S, Hirose H, Tilson MD: Two hypothetical proteins of human aortic adventitia, with Ig kappa, collagenous, and aromatic-rich motifs. Biochem Biophys Res Commun 225:500-504, 1996.
50. Pakarinen S: Incidence, aetiology, and prognosis of primary subarachnoid haemorrhage: A study based on 589 cases diagnosed in a defined urban population during a defined period. Acta Neurol Scand 43:[Suppl 29]:1-28, 1967.
51. Pearce WH, Koch AE: Cellular components and features of immune response in abdominal aortic aneurysms. Ann N Y Acad Sci 800:175-185, 1996.
52. Romanic AM, Madri JA: The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J Cell Biol 125:1165-1178, 1994.
53. Rosenorn J, Eskesen V, Schmidt K, Espersen JO, Haase J, Harmsen A, Hein O, Knudsen V, Midholm S, Marcussen E, Rhonde F: Clinical features and outcome in 1076 patients with ruptured intracranial saccular aneurysms: A prospective consecutive study. Br J Neurosurg 1:33-45, 1987.
54. Rosenorn J, Ronde F, Eskesen V, Schmidt K: Seasonal variation of aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 93:24-27, 1988.
55. Ross R: Atherosclerosis: An inflammatory disease. N Engl J Med 340:115-126, 1999.
56. Rus HG, Niculescu F, Vlaicu R: Co-localization of terminal C5b-9 complement complexes and macrophages in human atherosclerotic arterial walls. Immunol Lett 19:27-32, 1988.
57. Rus HG, Niculescu F, Vlaicu R: The relationship between macrophages and c5b-9 complement complexes in human atherosclerosis. Clin Immunol Immunopathol 48:307-316, 1988.
58. Ryba M, Jarzabek-Chorzelska M, Chorzelski T, Pastuszko M: Is vascular angiopathy following intracranial aneurysm rupture immunologically mediated? Acta Neurochir (Wien) 117:34-37, 1992.
59. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL: Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339:883-887, 1992.
60. Schievink WI: Intracranial aneurysms [published erratum appears in N Engl J Med 336:1267, 1997]. N Engl J Med 336:28-40, 1997.
61. Schroeder AP, Falk E: Pathophysiology and inflammatory aspects of plaque rupture. Cardiol Clin 14:211-220, 1996.
62. Seifert PS, Messner M, Roth I, Bhakdi S: Analysis of complement C3 activation products in human atherosclerotic lesions. Atherosclerosis 91:155-162, 1991.
63. Sekhar LN, Heros RC: Origin, growth, and rupture of saccular aneurysms: A review. Neurosurgery 8:248-260, 1981.
64. Sluiter W, Pietersma A, Lamers JM, Koster JF: Leukocyte adhesion molecules on the vascular endothelium: Their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J Cardiovasc Pharmacol 22[Suppl 4]: S37-S44, 1993.
65. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M: Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 92:8264-8268, 1995.
66. Stehbens WE: Etiology of intracranial berry aneurysms. J Neurosurg 70:823-831, 1989.
67. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK: T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A 92:3893-3897, 1995.
68. Taylor CL, Yuan Z, Selman, WR, Ratcheson RA, Rimm AA: Cerebral arterial aneurysm formation and rupture in 20,767 elderly patients: Hypertension and other risk factors. J Neurosurg 83: 812-819, 1995.
69. Tilson MD: Similarities of an autoantigen in aneurysmal disease of the human abdominal aorta to a 36-kDa microfibril-associated bovine aortic glycoprotein. Biochem Biophys Res Commun 213: 40-43, 1995.
70. Tilson MD, Ozsvath KJ, Hirose H, Xia S, Lahita R: A novel hypothesis to explain the hemorrhagic and connective tissue manifestations of Ebola virus infection. Clin Immunol Immunopathol 81:303-306, 1996.
71. Todor DR, Lewis I, Bruno G, Chyatte D: Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2. Stroke 29:1580-1583, 1998.
72. van der Wal AC, Becker AE, Das PK: Medial thinning and atherosclerosis: Evidence for involvement of a local inflammatory effect. Atherosclerosis 103:55-64, 1993.
73. Virchow VR: Uber die akute Entzundung der Arterien. Virchows Arch A Pathol Anat Histopathol 1:272-378, 1847.
74. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ: The HLA-DRB1 locus as a genetic component in giant cell arteritis: Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. J Clin Invest 90:2355-2361, 1992.
75. Wiebers DO, Whisnant JP, O'Fallon WM: The natural history of unruptured intracranial aneurysms. N Engl J Med 304:696-698, 1981.
76. Winter GF, Hallam NF, Hargreaves FD, Molyneaux PJ, Burns SM, Inglis JM: Respiratory viruses in a hospitalized paediatric population in Edinburgh 1985-1994. J Infect 33:207-211, 1996.
77. Wood GS, Warnke R: Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. J Histochem Cytochem 29:1196-1204, 1981.
78. Wu R, Lefvert AK: Autoantibodies against oxidized low density lipoproteins (oxLDL): Characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL. Clin Exp Immunol 102:174-180, 1995.
79. Xia S, Ozsvath K, Hirose H, Tilson MD: Partial amino acid sequence of a novel 40-kDa human aortic protein, with vitronectin-like, fibrinogen-like, and calcium binding domains: Aortic aneurysm-associated protein-40 (AAAP-40) [human MAGP-3, proposed]. Biochem Biophys Res Commun 219:36-39, 1996.